Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
A qualitative drug screen is a laboratory procedure designed to detect the presence or absence of specific drugs or drug classes in a biological specimen. This type of screening does not measure the concentration or amount of the drug; rather, it simply indicates whether the drug is present. The procedure can be performed using various methods, including chromatographic techniques for multiple drug classes or immunoassay and enzyme assay methods for a single drug class. The specimens used for testing can include blood serum, urine, saliva, sweat, hair, or other biological materials. The qualitative nature of the test means that it is primarily used for initial screening purposes, often in clinical settings or for substance abuse monitoring. The testing process for a single drug class typically involves introducing specific substances that react in the presence of the target drug, allowing for a straightforward determination of whether the drug is present in the specimen. This method is commonly automated, enhancing efficiency and accuracy in the testing process.
© Copyright 2026 Coding Ahead. All rights reserved.
The qualitative drug screen using CPT® Code 80101 is indicated for the following:
The procedure for conducting a qualitative drug screen using CPT® Code 80101 involves several key steps:
After the qualitative drug screen is completed, the results are typically reviewed and reported to the requesting physician or facility. If a positive result is obtained, further confirmatory testing may be recommended to verify the presence of the drug and to rule out false positives. It is important for healthcare providers to discuss the results with the patient, especially in cases where the findings may impact treatment decisions or legal matters. Additionally, proper documentation of the testing process and results is essential for compliance and record-keeping purposes.
| Short Descr | DRUG SCREEN SINGLE | Medium Descr | DRUG SCR QUAL 1 DRUG CLASS METH EA DRUG CLASS | Long Descr | Drug screen, qualitative; single drug class method (eg, immunoassay, enzyme assay), each drug class | Status Code | Not Valid for Medicare Purposes | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 9 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Non-Covered Service, not paid under OPPS | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | Not applicable/unspecified. | CCS Clinical Classification | 206 - Microscopic examination (bacterial smear, culture, toxicology) |
Get instant expert-level medical coding assistance.